Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

India needs Rs 5000 crore investment to produce 130 crore COVID vaccines: Zydus Cadila Chairman

Ruchika Sharma22 Sept 2020 12:00 PM IST

New Delhi: As the world waits expectantly for COVID-19 vaccine, Zydus Cadila Chairman Pankaj R Patel said India would need to invest between Rs...

BDR Pharma unveils prostate cancer drug enzalutamide at Rs 24480 per pack in India

Ruchika Sharma22 Sept 2020 11:30 AM IST

The 80 mg version is an attempt to reduce the pill burden as it is expected to increase the patient compliance, it added.

Natco Pharma to launch new products in non-oncology segment

Ruchika Sharma22 Sept 2020 11:00 AM IST

New Delhi: Natco Pharma plans to diversify its product portfolio in the domestic market as it aims to make up for a drop in business of some of its...

Development of COVID-19 vaccines: Pharma firms committed to science first approach, says Singapore Industry Body

Ruchika Sharma22 Sept 2020 10:00 AM IST

Singapore: Pharmaceutical companies are committed to a "science first" approach in the development of COVID-19 vaccines even as the pressure...

Biocon, APSSDC ink MoU to set up skill colleges across Andhra Pradesh

Ruchika Sharma20 Sept 2020 12:00 PM IST

Biocon will also help APSSDC in designing the curriculum, training faculty, offering industrial training and visits, identifying the equipment...

Union Minister Gowda lauds contribution of Indian pharma industry amid COVID-19 crisis

Ruchika Sharma20 Sept 2020 11:30 AM IST

Union Minister also stressed that the Indian pharma and medical devices industry was able to rise to the occasion.

Roche Tecentriq, Avastin combo gets positive CHMP opinion for liver cancer

Ruchika Sharma20 Sept 2020 10:00 AM IST

Basel: Roche has recently announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended...

Punjab to bid for bulk drug park in Bathinda under Centre scheme

Ruchika Sharma20 Sept 2020 9:30 AM IST

An estimated cost of the project is Rs 1,878 crore, including the cost of infrastructure facilities.

Sanofi, Health2Sync ink pact for digital solution to diabetes management

Ruchika Sharma20 Sept 2020 9:00 AM IST

Taipei: Health2Sync, a digital health startup, specializing in diabetes management, has entered into a partnership with Sanofi, a biopharmaceutical...

S Aparna takes charge as Secretary, Department of Pharmaceuticals

Ruchika Sharma19 Sept 2020 2:36 PM IST

New Delhi: The Appointments Committee of the Cabinet recently appointed Senior bureaucrat, S Aparna, as Secretary, Department of Pharmaceuticals...

FIRST: Russia okays R-Pharm Covid-19 prescription drug for sale in pharmacies

Ruchika Sharma19 Sept 2020 2:00 PM IST

R-Pharm has started talks with pharmacies about orders, the company's spokeswoman said, with Coronavir supplies expected to be rolled out in the near...

GSK, Sanofi to provide 300 million doses of COVID-19 vaccine to EU

Ruchika Sharma19 Sept 2020 1:15 PM IST

A Phase 3 study is planned to begin by the end of 2020 and regulatory approval could be requested in the first half of 2021.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok